Our top pick for
Long-term investors
Kindred Biosciences Inc is a drug manufacturers-specialty & generic business based in the US. Kindred Biosciences shares (KIN) are listed on the NASDAQ and all prices are listed in US Dollars. Kindred Biosciences employs 63 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Kindred Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KIN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kindred Biosciences stock price (NASDAQ: KIN)
Use our graph to track the performance of KIN stocks over time.Kindred Biosciences shares at a glance
Information last updated 2021-10-17.
| Latest market close | $4.83 |
|---|---|
| 52-week range | $4.11 - $9.28 |
| 50-day moving average | $9.20 |
| 200-day moving average | $6.64 |
| Wall St. target price | $9.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.02 |
Buy Kindred Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kindred Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kindred Biosciences price performance over time
Historical closes compared with the close of $4.83 from 2021-05-28
| 1 week (2022-01-14) | N/A |
|---|---|
| 1 month (2021-12-21) | N/A |
| 3 months (2021-10-21) | N/A |
| 6 months (2021-07-25) | -47.21% |
| 1 year (2021-01-25) | -0.62% |
|---|---|
| 2 years (2020-01-24) | -49.16% |
| 3 years (2019-01-25) | 10.06 |
| 5 years (2017-01-25) | 6.4 |
Kindred Biosciences financials
| Revenue TTM | $5.8 million |
|---|---|
| Gross profit TTM | $-1,162,000 |
| Return on assets TTM | -23.11% |
| Return on equity TTM | -50.36% |
| Profit margin | 0% |
| Book value | $1.76 |
| Market capitalisation | $420.5 million |
TTM: trailing 12 months
Kindred Biosciences share dividends
We're not expecting Kindred Biosciences to pay a dividend over the next 12 months.
Kindred Biosciences share price volatility
Over the last 12 months, Kindred Biosciences's shares have ranged in value from as little as $4.105 up to $9.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kindred Biosciences's is 1.3152. This would suggest that Kindred Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Kindred Biosciences overview
Kindred Biosciences, Inc. , a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California. As of August 27, 2021, Kindred Biosciences, Inc.
Kindred Biosciences in the news
Frequently asked questions
What percentage of Kindred Biosciences is owned by insiders or institutions?Currently 19.041% of Kindred Biosciences shares are held by insiders and 80.102% by institutions. How many people work for Kindred Biosciences?
Latest data suggests 63 work at Kindred Biosciences. When does the fiscal year end for Kindred Biosciences?
Kindred Biosciences's fiscal year ends in December. Where is Kindred Biosciences based?
Kindred Biosciences's address is: 1555 Bayshore Highway, Burlingame, CA, United States, 94010 What is Kindred Biosciences's ISIN number?
Kindred Biosciences's international securities identification number is: US4945771099 What is Kindred Biosciences's CUSIP number?
Kindred Biosciences's Committee on Uniform Securities Identification Procedures number is: 494577109
More guides on Finder
-
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
-
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
-
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
-
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
-
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
-
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
-
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
-
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
-
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
-
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Ask an Expert